Q3 2025 Scientific Industries Inc Earnings Call Transcript
Key Points
- Scientific Industries Inc (SCND) successfully divested its legacy Genie products division, marking a significant strategic shift.
- The company introduced a new AI-driven feature to its VIVID Workstation, enhancing regulatory compliance and cost savings for customers.
- The DOTS platform is gaining strategic interest from biomanufacturing organizations, highlighting its potential in AI and advanced analytics.
- Q3 2025 was the strongest revenue quarter of the year, with a 50% increase over Q2, indicating improving sales performance.
- The company is seeing increased OEM collaborations and interest in integrating DOTS into next-generation systems, suggesting future growth opportunities.
- The bioprocessing segment continues to face a challenging market environment with tight budgets and high competition for funding.
- New technologies face higher adoption hurdles due to risk-averse customers and the need for mature, robust products.
- The market environment remains selective and cost-cautious, impacting capital spending decisions.
- Q3 reflected typical industry seasonality, leading to a softer top of the funnel compared to the first half of the year.
- Despite improvements, the overall market is normalizing only gradually, indicating ongoing external challenges.
Good day, and welcome to the Scientific Industries reports third quarter fiscal year 2025 financial results conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Joe Dorame, Managing Partner. Please go ahead.
Thanks, Bailey. Good morning, and thank you for joining us today to review Scientific Industries financial results for the third quarter of 2025 ended September 30, 2025. With us today on the call are Helena Santos, Chief Executive Officer; Daniel Donadille, CEO of SBI; and John Moore, Chairman. After the conclusion of today's prepared remarks, we'll open the call for questions.
Before we begin with prepared remarks, I would like to remind everyone certain statements made by the management team of Scientific Industries during this conference call constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Except for the statements of historical fact, this conference call may contain forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

